Development of a unified clinical trial database for Alzheimer's disease-Reference-Cited by-同舟云学术

Development of a unified clinical trial database for Alzheimer's disease

Published:2015-02-09 Issue:10 Volume:11 Page:1212-1221
ISSN:1552-5260
Container-title:Alzheimer's & Dementia
language:en
Short-container-title:Alzheimer's & Dementia

Author:

Neville Jon¹,Kopko Steve²,Broadbent Steve¹,Avilés Enrique¹,Stafford Robert¹,Solinsky Christine M.³,Bain Lisa J.⁴,Cisneroz Martin¹,Romero Klaus¹,Stephenson Diane¹,

Affiliation:

1. Coalition Against Major Diseases (CAMD) Critical Path Institute Tucson AZ USA

2. CDISC Austin TX USA

3. USC Department of Pharmaceutical Sciences USA

4. Independent Science Writer Elverson PA USA

Funder

Science Foundation Arizona

U.S. Food and Drug Administration

Publisher

Wiley

Subject

Psychiatry and Mental health,Cellular and Molecular Neuroscience,Geriatrics and Gerontology,Neurology (clinical),Developmental Neuroscience,Health Policy,Epidemiology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1016/j.jalz.2014.11.005

Reference34 articles.

1. Alzheimer's Disease International.World Alzheimer's report. 2009.

2. Food and Drug Administration.Innovation or stagnation: challenges and opportunity on the critical path to new medical products.2004. Available at:http://www.fda.gov/ScienceResearch/SpecialTopics/CriticalPathInitiative/CriticalPathOpportunitiesReports/ucm077262.htm. Accessed February 26 2013.

3. Striving for an integrated drug development process for neurodegeneration: the coalition against major diseases;Romero K;Neurodegen Dis Manage,2011

4. The Coalition Against Major Diseases: Developing Tools for an Integrated Drug Development Process for Alzheimer’s and Parkinson’s Diseases

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. ClinicalGAN: powering patient monitoring in clinical trials with patient digital twins;Scientific Reports;2024-05-28

2. APOE-ε4 allele[s]-associated adverse events reported from placebo arm in clinical trials for Alzheimer's disease: implications for anti-amyloid beta therapy;Frontiers in Dementia;2024-01-15

3. Simulation-based power analysis could improve the design of clinical trials in Alzheimer’s disease;2022-12-27

4. Clinical Data Interchange Standards in Clinical Trials on Alzheimer’s Disease;Psychiatry Investigation;2022-10-25

5. Individualized Tracking of Neurocognitive-State-Dependent Eye-Movement Features Using Mobile Devices;Proceedings of the ACM on Interactive, Mobile, Wearable and Ubiquitous Technologies;2022-03-27